Contineum Therapeutics
CTNM
#7857
Rank
NZ$0.75 B
Marketcap
NZ$19.35
Share price
1.99%
Change (1 day)
0.66%
Change (1 year)

Earnings for Contineum Therapeutics (CTNM)

Earnings in 2026 (TTM): -NZ$0.12 Billion

According to Contineum Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.11 Billion a decrease over its 2024 earnings that were of -NZ$75.93 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Contineum Therapeutics from 2023 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.12 Billion3.15%
2025 -NZ$0.11 Billion41.93%
2024 -NZ$75.93 Million-282.38%
2023 NZ$41.63 M